Cargando…
Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others
Bone marrow samples from discarded femoral heads are often used as healthy controls in studies investigating the in vitro characteristics of cells from patients with hematologic malignancies. Since patient samples are usually derived from iliac crest aspirates, this carries the risk that the propert...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993599/ https://www.ncbi.nlm.nih.gov/pubmed/36882822 http://dx.doi.org/10.1186/s13287-023-03257-z |
_version_ | 1784902545999659008 |
---|---|
author | Rivière, Jennifer Hock, Jennifer Buck, Michèle C. Hecker, Judith S. Götze, Katharina S. van der Garde, Mark |
author_facet | Rivière, Jennifer Hock, Jennifer Buck, Michèle C. Hecker, Judith S. Götze, Katharina S. van der Garde, Mark |
author_sort | Rivière, Jennifer |
collection | PubMed |
description | Bone marrow samples from discarded femoral heads are often used as healthy controls in studies investigating the in vitro characteristics of cells from patients with hematologic malignancies. Since patient samples are usually derived from iliac crest aspirates, this carries the risk that the properties of the cells from both sources might be different due to the site and method of harvesting. Comparing BM cells from iliac crest aspirates and femoral heads from age-matched healthy donors, we show that, while mesenchymal stromal cells have indistinguishable properties between both sources, hematopoietic stem and progenitor cells (HSPC) from femoral heads show a considerable proliferative advantage in vitro. These data therefore suggest that experiments comparing leukemic cells from the iliac crest to healthy HSPC obtained from femoral heads should be interpreted with caution. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03257-z. |
format | Online Article Text |
id | pubmed-9993599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99935992023-03-09 Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others Rivière, Jennifer Hock, Jennifer Buck, Michèle C. Hecker, Judith S. Götze, Katharina S. van der Garde, Mark Stem Cell Res Ther Short Report Bone marrow samples from discarded femoral heads are often used as healthy controls in studies investigating the in vitro characteristics of cells from patients with hematologic malignancies. Since patient samples are usually derived from iliac crest aspirates, this carries the risk that the properties of the cells from both sources might be different due to the site and method of harvesting. Comparing BM cells from iliac crest aspirates and femoral heads from age-matched healthy donors, we show that, while mesenchymal stromal cells have indistinguishable properties between both sources, hematopoietic stem and progenitor cells (HSPC) from femoral heads show a considerable proliferative advantage in vitro. These data therefore suggest that experiments comparing leukemic cells from the iliac crest to healthy HSPC obtained from femoral heads should be interpreted with caution. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03257-z. BioMed Central 2023-03-08 /pmc/articles/PMC9993599/ /pubmed/36882822 http://dx.doi.org/10.1186/s13287-023-03257-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Short Report Rivière, Jennifer Hock, Jennifer Buck, Michèle C. Hecker, Judith S. Götze, Katharina S. van der Garde, Mark Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
title | Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
title_full | Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
title_fullStr | Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
title_full_unstemmed | Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
title_short | Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
title_sort | choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993599/ https://www.ncbi.nlm.nih.gov/pubmed/36882822 http://dx.doi.org/10.1186/s13287-023-03257-z |
work_keys_str_mv | AT rivierejennifer choosingthesourceofhealthycontrolsforstudiesonmyeloidmalignanciesallbonemarrowcellsarecreatedequalbutsomearemoreequalthanothers AT hockjennifer choosingthesourceofhealthycontrolsforstudiesonmyeloidmalignanciesallbonemarrowcellsarecreatedequalbutsomearemoreequalthanothers AT buckmichelec choosingthesourceofhealthycontrolsforstudiesonmyeloidmalignanciesallbonemarrowcellsarecreatedequalbutsomearemoreequalthanothers AT heckerjudiths choosingthesourceofhealthycontrolsforstudiesonmyeloidmalignanciesallbonemarrowcellsarecreatedequalbutsomearemoreequalthanothers AT gotzekatharinas choosingthesourceofhealthycontrolsforstudiesonmyeloidmalignanciesallbonemarrowcellsarecreatedequalbutsomearemoreequalthanothers AT vandergardemark choosingthesourceofhealthycontrolsforstudiesonmyeloidmalignanciesallbonemarrowcellsarecreatedequalbutsomearemoreequalthanothers |